[go: up one dir, main page]

NO981633D0 - Farmas÷ytisk blanding for administrering av en aktiv forbindelse til eller gjennom hud eller en mukosaoverflate - Google Patents

Farmas÷ytisk blanding for administrering av en aktiv forbindelse til eller gjennom hud eller en mukosaoverflate

Info

Publication number
NO981633D0
NO981633D0 NO981633A NO981633A NO981633D0 NO 981633 D0 NO981633 D0 NO 981633D0 NO 981633 A NO981633 A NO 981633A NO 981633 A NO981633 A NO 981633A NO 981633 D0 NO981633 D0 NO 981633D0
Authority
NO
Norway
Prior art keywords
administering
skin
active compound
pharmaceutical
mucosa
Prior art date
Application number
NO981633A
Other languages
English (en)
Other versions
NO981633L (no
Inventor
Lise Sylvest Nielsen
Jens Hansen
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Publication of NO981633D0 publication Critical patent/NO981633D0/no
Publication of NO981633L publication Critical patent/NO981633L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO981633A 1995-10-12 1998-04-08 Farmas÷ytisk blanding for administrering av en aktiv forbindelse til eller gjennom hud eller en mukosaoverflate NO981633L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK115095 1995-10-12
PCT/DK1996/000437 WO1997013528A1 (en) 1995-10-12 1996-10-11 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface

Publications (2)

Publication Number Publication Date
NO981633D0 true NO981633D0 (no) 1998-04-08
NO981633L NO981633L (no) 1998-06-04

Family

ID=8101575

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981633A NO981633L (no) 1995-10-12 1998-04-08 Farmas÷ytisk blanding for administrering av en aktiv forbindelse til eller gjennom hud eller en mukosaoverflate

Country Status (7)

Country Link
EP (1) EP0871489A1 (no)
JP (1) JPH11513393A (no)
AU (1) AU702030B2 (no)
CA (1) CA2231273A1 (no)
FI (1) FI980822A0 (no)
NO (1) NO981633L (no)
WO (1) WO1997013528A1 (no)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
CA2286052A1 (en) * 1997-04-17 1998-10-29 Lise Sylvest Nielsen A novel bioadhesive drug delivery system based on liquid crystals
WO1999001579A1 (en) 1997-07-01 1999-01-14 Isis Pharmaceuticals, Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal
WO1999007341A1 (en) * 1997-08-09 1999-02-18 Smithkline Beecham Plc Compositions for nasal administration
ES2202901T3 (es) * 1997-09-09 2004-04-01 Lyotropic Therapeutics, Inc. Particulas recubiertas, procedimiento para su fabricacion y uso.
SE9703458D0 (sv) * 1997-09-25 1997-09-25 Pharmacia & Upjohn Ab Nicotine compositions and methods of formulation thereof
WO1999060012A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB9827034D0 (en) * 1998-12-10 1999-02-03 Univ Manchester Delivery formulation
ATE280571T1 (de) * 1999-08-06 2004-11-15 Max Delbrueck Centrum Implantierbares wirkstoffdepot
WO2001045727A2 (en) * 1999-12-20 2001-06-28 New Pharma Research Sweden Ab Stabilized veterinary compositions comprising more than one antiviral agent
DE10057769A1 (de) 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
HUP0400732A3 (en) * 2001-04-30 2007-05-29 Trommsdorff Arzneimittel Pharmaceutically active uridine esters
US7439271B2 (en) * 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
US20030124196A1 (en) 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
JP2007504256A (ja) * 2003-09-01 2007-03-01 メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド 生物活性剤の送達のための組成物及び方法
NZ551990A (en) 2004-06-04 2011-01-28 Camurus Ab Liquid depot formulations
EP1812022B1 (en) 2004-09-28 2014-01-15 Atrium Medical Corporation Stand-alone film and methods for making the same
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036982A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Drug delivery coating for use with a stent
DE602005026998D1 (de) 2005-01-14 2011-04-28 Camurus Ab Somatostatin-analog-formulierungen
PL1848403T3 (pl) * 2005-01-14 2010-09-30 Camurus Ab Preparaty bioadhezyjne o działaniu miejscowym
KR100983746B1 (ko) * 2005-01-14 2010-09-24 카무러스 에이비 소마토스타틴 유사 제형
SI1845942T1 (sl) * 2005-01-14 2014-06-30 Camurus Ab Gnrh analogne formulacije
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
AU2005325510B2 (en) 2005-01-21 2009-07-02 Camurus Ab Pharmaceutical lipid compositions
CA2607626A1 (en) * 2005-05-10 2006-11-16 Novartis Ag Modified release famciclovir pharmaceutical compositions
CA2609810C (en) 2005-06-06 2012-05-22 Camurus Ab Glp-1 analogue formulations
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
AU2006304590A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
MX2009004038A (es) 2006-10-17 2009-08-24 Nuvo Res Gel de diclofenaco.
EP2626091B1 (en) 2006-11-06 2016-09-28 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
US8783089B2 (en) * 2008-06-09 2014-07-22 Boehringer Ingelheim International Gmbh Device and method for determining the properties of aerosol formulations
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
WO2010150262A2 (en) * 2009-06-25 2010-12-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Reverse hexagonal mesophases (hii) and uses thereof
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
WO2013174978A1 (en) 2012-05-25 2013-11-28 Camurus Ab Somatostatin receptor agonist formulations
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
NZ704012A (en) 2012-07-26 2017-09-29 Camurus Ab Opioid formulations
EP3326613A1 (en) 2012-07-26 2018-05-30 Camurus AB Opioid formulations
EP3612166A4 (en) 2017-04-20 2020-11-04 Zeenar Enterprises Pty Ltd LIQUID CRYSTAL GALENIC FORM FOR THE ADMINISTRATION OF STATIN
JP7603972B2 (ja) * 2018-09-07 2024-12-23 株式会社ファルネックス 非ラメラ液晶形成脂質を含む外用剤
CA3117606A1 (en) * 2018-10-25 2020-04-30 Zeenar Enterprises Pty Ltd Composition that forms liquid crystalline particles
CN111821254B (zh) * 2019-04-18 2021-10-15 华东师范大学 一种抗病毒水凝胶及其制备方法和应用
CN111759858B (zh) * 2020-06-02 2022-09-20 杭州英健生物科技有限公司 pH敏感型消化道粘膜保护胶及其应用
CN112791047A (zh) * 2021-01-15 2021-05-14 中国人民解放军总医院第三医学中心 一种白藜芦醇层状液晶及其制备方法
EP4419884A2 (en) * 2021-10-19 2024-08-28 Sensach AB Lipid patch
WO2023189273A1 (ja) * 2022-03-28 2023-10-05 富士フイルム株式会社 生体用組成物
WO2023189270A1 (ja) * 2022-03-28 2023-10-05 富士フイルム株式会社 生体用組成物
WO2024068672A1 (en) * 2022-09-26 2024-04-04 Universität Bern Structured lipid compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2631282A1 (de) * 1976-07-12 1978-01-19 Kali Chemie Pharma Gmbh Verfahren zur erhoehung der loeslichkeit und des dispersitaetsgrades von schwerloeslichen arzneistoffen zum zwecke deren applikation in gelatinekapseln
SE457933B (sv) * 1987-07-06 1989-02-13 Larsson Kare Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion
DK0448091T3 (da) * 1990-03-23 1999-05-03 Yoshitomi Pharmaceutical Farmaceutisk præparat indeholdende et i ringe grad vandopløseligt medikament
CA2186750C (en) * 1994-03-30 2008-08-05 Jens Hansen Use of fatty acid esters as bioadhesive substances

Also Published As

Publication number Publication date
WO1997013528A1 (en) 1997-04-17
AU702030B2 (en) 1999-02-11
NO981633L (no) 1998-06-04
FI980822A (fi) 1998-04-09
AU7279296A (en) 1997-04-30
JPH11513393A (ja) 1999-11-16
FI980822A0 (fi) 1998-04-09
CA2231273A1 (en) 1997-04-17
EP0871489A1 (en) 1998-10-21

Similar Documents

Publication Publication Date Title
NO981633D0 (no) Farmas÷ytisk blanding for administrering av en aktiv forbindelse til eller gjennom hud eller en mukosaoverflate
IS2537B (is) Lyfjablanda til inngjafar um húð
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
NL194780B (nl) Oraal therapeutisch systeem voor toediening van een anticonvulsivum.
AU6273796A (en) Nucleotide analogues for topical treatment of proliferative disease of the skin
NO974480D0 (no) Anvendelse av vitamin D2 eller vitamin D4 derivater til fremstilling av et medikament for behandling av sekundær hyperparathyreoidisme
NO863670D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat av et hydrofobt legemiddel.
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
DK362189A (da) Farmaceutisk praeparat til intravenoes indgift
BR9600821A (pt) Composto formulação farmacêutica e processo para a preparação de um composto
NO178564C (no) Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner
NO892826D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for aa forhindre seksuelt overfoerbare sykdommer.
AU4048295A (en) Peptide medicaments for the treatment of disease
NO173873C (no) Analogifremgangsmaate til fremstilling av en terapeutisk aktiv monosakkaridforbindelse
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
NO883500D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
AU6934691A (en) Transdermal administration of zwitterionic drugs
PT801561E (pt) Composicao e metodos para a entrega transdermica de drogas labeis a acido
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
DE3874072D1 (de) Arzneimittel fuer die kombination piperidinoalkanol-dekongestivum.
NO20001893D0 (no) Fremgangsmõte for behandling av dyskinesi relatert til sykdom eller som er indusert av medikamenter
NO982875L (no) Tablett med hurtig frigivelse omfattende tolfenaminsyre eller et farmasöytisk akseptabelt salt av denne
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
DK298389A (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application